Nemonoxacin Malate (TG-873870; TG873870; TG 873870), the maleate salt of nemonoxacin, is novel quinolone antibiotic with a broad-spectrum activity against strains such as Gram+, Gram- and atypical pathogens, including drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus.
Physicochemical Properties
| Molecular Formula | C24H31N3O9 |
| Molecular Weight | 505.51764 |
| Exact Mass | 505.206 |
| CAS # | 951163-60-3 |
| Related CAS # | Nemonoxacin;378746-64-6 |
| PubChem CID | 49863435 |
| Appearance | White to off-white solid powder |
| LogP | 1.888 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 36 |
| Complexity | 776 |
| Defined Atom Stereocenter Count | 2 |
| SMILES | OC(CC(C(=O)O)O)=O.C[C@H]1C[C@H](N)CN(C2C=CC3=C(N(C4CC4)C=C(C3=O)C(=O)O)C=2OC)C1 |
| InChi Key | YMVJINCWEIPOFL-FXMYHANSSA-N |
| InChi Code | InChI=1S/C20H25N3O4.C4H6O5/c1-11-7-12(21)9-22(8-11)16-6-5-14-17(19(16)27-2)23(13-3-4-13)10-15(18(14)24)20(25)26;5-2(4(8)9)1-3(6)7/h5-6,10-13H,3-4,7-9,21H2,1-2H3,(H,25,26);2,5H,1H2,(H,6,7)(H,8,9)/t11-,12-;/m0./s1 |
| Chemical Name | 7-((3S,5S)-3-amino-5-methylpiperidin-1-yl)-1-cyclopropyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid malate |
| Synonyms | TG-873870 TG873870 TG 873870 Nemonoxacin Malate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Nemonoxacin exhibits antibacterial activity against Chlamydia pneumoniae, as evidenced by a MIC90 of 0.06 μg/mL [1]. While vancomycin MRSA (MIC90) has limited effectiveness at 2 μg/ml, nemofloxacin is extremely active against community-acquired MRSA (CA-MRSA) (MIC90: 0.5 and 0.06 μg/ml) and intermediate against ciprofloxacin-resistant MRSA (MIC90: 1 μg/ml) [2]. |
| References |
[1]. Chotikanatis K, et al. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother. 2014;58(3):1800-1. [2]. Lai CC, et al. Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther. 2014 Apr;12(4):401-17. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~197.82 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (4.95 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (4.95 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (4.95 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9782 mL | 9.8908 mL | 19.7816 mL | |
| 5 mM | 0.3956 mL | 1.9782 mL | 3.9563 mL | |
| 10 mM | 0.1978 mL | 0.9891 mL | 1.9782 mL |